WPD Pharmaceuticals is a Polish biotech company developing innovative oncology therapies for high-mortality cancers. While initially focused on lethal brain tumors like glioblastoma, WPD has built a diverse pipeline of patented drug candidates (licensed from Wake Forest University) including cutting-edge antibody-drug conjugates. Our flagship ADC, WPD401, co-developed with Wake Forest, uniquely targets four tumor-specific receptors (IL-13Rα2, EphA2, EphA3, EphB2) found in some of the toughest-to-treat cancers. Originally designed for glioblastoma, WPD401 has shown potent activity in other aggressive tumors that overexpress these receptors – for example, triple-negative breast, pancreatic, and certain lung cancers – thereby broadening its clinical potential into multiple high-need indications. Backed by this innovative multi-target approach and encouraging preclinical results, WPD is now advancing toward clinical trials in the United States. We are actively seeking strategic partners to co-develop and unlock the full potential of our pipeline, with the aim of delivering life-changing therapies for patients with limited treatment options. The controlling shareholder of WPD
Poland is ACRX Investments Limited.
Company Details
- Employees
- 11
- Founded
- -
- Address
- Ochota, Mazowieckie 02-089, Pl
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- wpdpharmaceuticals.com
- HQ
- Ochota, Mazowieckie
Wpd Pharmaceuticals Sp. Z O.o. Questions
Wpd Pharmaceuticals Sp. Z O.O.'s website is wpdpharmaceuticals.com
Wpd Pharmaceuticals Sp. Z O.O.'s LinkedIn profile is https://pl.linkedin.com/company/wpd-pharmaceuticals-spzoo
Wpd Pharmaceuticals Sp. Z O.O. has
11 employees.
View email and phone details for 11
employees at Wpd Pharmaceuticals Sp. Z O.O..
Wpd Pharmaceuticals Sp. Z O.O.'s industry is
Biotechnology Research
Wpd Pharmaceuticals Sp. Z O.O.'s top competitors are
Biotechna S.a.,
Jjp Biologics,
Famicordtx 🧬 Gene Therapies,
Pikralida,
Molecure,
Celon Pharma S.a.,
Captor Therapeutics Sa,
Pure Biologics,
Ryvu Therapeutics,
Ardigen.
Wpd Pharmaceuticals Sp. Z O.O.'s categories are Biotechnology Research
Wpd Pharmaceuticals Sp. Z O.O.'s founding year is 2017
